Taiwan Clinical Trial Results of 2cPA Presented at OARSI 2024

May 1, 2024

• At the 2024 OARSI World Congress on Osteoarthritis,
  held from April 18–21, 2024 in Vienna, Austria,

  Dr. Ikuko Masuda (Head of Rheumatology,
  Jujo Takeda Rehabilitation Hospital / Visiting Lecturer, Tokyo Women’s Medical University),

  a member of our Scientific Advisory Board,
  presented the clinical trial results from Taiwan on

  2-carba cyclic phosphatidic acid (2ccPA; synthetic compound, drug candidate) 

• for osteoarthritis.